In 5-aza-2-deoxycytidine-treated HCC cell lines, the induction of p16INK4a upregulation, pRB dephosphorylation, and G1 arrest was indicated by positive SA-β-Gal staining (49). Here, CDKN2A is linked to hepatocellular carcinoma.